Thibaud Portal is the founder of Alys Pharmaceuticals. Alys Pharmaceuticals has raised $100M in total funding. Latest round: Seed. Backed by Medicxi.
Thibaud Portal is the founder, Chief Executive Officer, and Chief Operating Officer of Alys Pharmaceuticals, an immuno-dermatology company launched in February 2024. He previously co-founded six biotechnology startups that merged to form Alys, bringing a pipeline of skin disease drugs to the new entity. Portal is also a Venture Partner at Medicxi Ventures (Jersey) Ltd.
Full founder directory · Investor directory · Company funding database · Fundraising library